ROCKVILLE, Md. — OriGene Technologies, Inc. today announced Royal Institute of Technology in Sweden has adopted its VERIFY Tagged Antigen(TM) (Over-expression Lysates) in the Human Protein Atlas program. This program is funded by the Knut and Alice Wallenberg Foundation and is set up to explore the human proteome systematically using Antibody-Based Proteomics. “Generating high quality […]
Transaction adds to QIAGEN’s content engine for development of future diagnostics and boosts the Company’s presence in pharma discovery and validation VENLO, The Netherlands — QIAGEN N.V. (NASDAQ: QGEN; Frankfurt, Prime Standard: QIA) today announced that it has signed a definite agreement to acquire SABiosciences Corporation, a privately-held developer and manufacturer of disease- and pathway-focused […]
Royal Institute of Technology Adopts OriGene Over-Expression Lysates in Human Proteome Atlas Program
Rockville, Maryland — OriGene Technologies, Inc. today announced Royal Institute of Technology in Sweden has adopted its VERIFY Tagged Antigen™ (Over-expression Lysates) in the Human Protein Atlas program. This program is funded by the Knut and Alice Wallenberg Foundation and is set up to explore the human proteome systematically using Antibody-Based Proteomics. “Generating high quality […]
UPPSALA, SWEDEN — Olink Bioscience a Sweden based biotechnology com-pany has entered into a distribution agreement with Axxora LLC for distribution of Olink Bioscience product line Duolink® in the North American market. Axxora, a major life science research distributor in San Diego, USA, will handle distribution and service of Olink Bioscience products. “We are proud […]
BUFFALO, N.Y. — Rand Capital Corporation (Nasdaq:RAND) (“Rand”), a business development company (BDC) that provides capital and managerial expertise for small to medium-sized private companies, announced that it has invested $250,000 in Rheonix, Inc. (www.rheonix.com), based in Ithaca, New York. Rheonix began operations and was later spun out of the microfluidic division of Kionix, Inc. […]
Leader in drug screening tools and technologies now has local sales teams in China and South Korea Bagnols-sur-Cèze, France – Cisbio Bioassays (www.htrf.com), a member of IBA group and global developer of HTRF® (Homogeneous Time-Resolved Fluorescence) technology and services used in assay development and drug screening, today announced that it has established sales operations in […]
WaferGen Names Christopher Sears, Ph.D., Architect of High-Value Molecular Diagnostics and Computational Biology Platforms, to Company’s Scientific Advisory Board FREMONT, Calif. — WaferGen Biosystems, Inc. (OTC Bulletin Board: WGBS – News), a leading developer of state-of-the-art genetic analysis systems, today announced that Christopher Sears, Ph.D. has joined the company’s Scientific Advisory Board. His career has […]
Less Expensive, More Reliable Rodent Panel Offers Both Predictivity and Mechanistic Profiles PITTSBURGH–Cellumen, Inc., a discovery and early safety assessment company, today announced that its in vitro Rat Hepatocyte Early Safety Assessment Panel provides increased predictivity for human drug induced liver injury (DILI) equivalent to that of a recently published panel comprised of human hepatocytes. […]
SpectralWorks AnalyzerPro software is core software for AgResearch metabolomics studies in New Zealand AgResearch Limited (www.agresearch.co.nz ), New Zealand’s largest Crown Research Institute (CRI) has entered into an agreement with SpectralWorks Limited for the supply and potential further development of their AnalyzerPro® MS data mining Software. Based at the Grasslands Research Centre in Palmerston North, […]
Cellectis bioresearch launches cGPS® CHO-S CEMAX® – an efficient protein production kit Paris — Cellectis bioresearch, a specialist in genome customization and a subsidiary of Cellectis S.A. (Alternext: ALCLS), today launched cGPS® CHO-S CEMAX®, a kit which enables targeted integration into suspension cell cultures. By reducing the amount of time required to obtain clones and […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
